Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

3 months ago

The success of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro caused the company to hike its guidance. 

More Stories

‘I feel anger’: Spain braces for more storms after deadly flash floods

45 mins ago

NATO leading military officer on Trump’s return and Middle East

45 mins ago

Trump is back. What does it mean for the US and the world?

45 mins ago

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

Hollywood filmmakers partner Kunle Afolayan to train young Nigerian filmmakers

45 mins ago

Benin vs. Nigeria Preview: Super Eagles eye AFCON qualification in Abidjan

45 mins ago

WHO raises alarm over rising cases of diabetes globally

45 mins ago

From early retirement to coaching Dubois against AJ | Kieran Farrell tells his story

45 mins ago

Winfield-Hill joins England coaching team for South Africa tour, Women’s Ashes

45 mins ago